Chinese pharmaceutical firm CGeneTech has raised over RMB100 million (US$14.52 million) in a series A+ round of financing led by Hongtai Capital, a venture capital firm co-established by the founder of Chinese education giant New Oriental Education.
Hongtai Capital Leads $14M Series A+ Round In Chinese Pharmaceutical Firm comes originally from China Money Network. All Rights Reserved.